Skip to main content

Dr. Herman Sintim

Dr. Herman Sintim

Research Interests

  • Novel chemical libraries via multi-component reactions.
  • New anticancer agents targeting G-quadruplexes and kinases.
  • The chemical biology of bacterial communication, virulence factors production and biofilm formation (quorum sensing and c-di-GMP/c-di-AMP signaling in bacteria).
  • The discovery of new antibiotics with novel modes of action.
  • Cyclic dinucleotide and STING signaling in immune cells.


  • BSc, University College London, 1999
  • Ph.D., University of Oxford, 2002
  • Postdoctoral Fellow, University of Oxford, 2004
  • Postdoctoral Fellow, Stanford University, 2006


  • Sigma Xi Distinguished Lecturer, 2015
  • Camille Dreyfus Teacher-Scholar Award, 2011
  • Allen Angerio Award for Excellence in Faculty Mentorship, 2010
  • Kavli Fellow (Indo-US Frontiers of science symposium, 2009
  • Career Award, 2008
  • UMD Invention of the year finalist, 2008
  • University of Maryland General Research Board Summer Research Award, 2007
  • Roche's top award, Switzerland (Leading Chemists of the Next Decade Symposium), 2002
  • First Innocentive Awardee (Eli Lilly): Profile featured in The Scientist, Volume 16 (1), page 60 (Seeking Scientific Riddle Solvers), 2001
  • Pfizer UK PhD Prize (First Prize Award), 2001
  • ORS fellowship, (University of Oxford), 2000
  • Pathfinder fellow, (University College London), 1996


List of publications